Company Filing History:
Years Active: 2009
Title: Manfred Jung: Innovator in SIRT1 Research
Introduction
Manfred Jung is a notable inventor based in Freiburg, Germany. He has made significant contributions to the field of biomedical research, particularly in the area of sirtuin activity modulation. His work focuses on developing innovative treatment methods for immunodeficiency virus infections, including HIV.
Latest Patents
Manfred Jung holds a patent titled "Screening methods for the identification of agents that inhibit SIRT1 Tat deacetylase activity." This invention provides treatment methods that involve modulating sirtuin activity, sirtuin mRNA, and sirtuin polypeptide levels. The patent outlines methods for inhibiting SIRT1 Tat deacetylase activity, which is crucial for treating immunodeficiency virus infections. The invention also includes methods for identifying agents that can modulate sirtuin activity, particularly in relation to viral substrates.
Career Highlights
Jung is affiliated with the University of California, where he continues to advance his research in the field of sirtuins. His work has implications for developing new therapeutic strategies against viral infections, showcasing his commitment to improving public health through scientific innovation.
Collaborations
Manfred Jung has collaborated with esteemed colleagues such as Melanie Ott and Eric M Verdin. These partnerships have enhanced the scope and impact of his research, contributing to the advancement of knowledge in the field.
Conclusion
Manfred Jung's innovative work in the modulation of sirtuin activity represents a significant advancement in the treatment of immunodeficiency virus infections. His contributions to science and medicine continue to inspire future research and development in this critical area.